You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

plasma EBV DNA

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nasopharyngeal Cancer Trial in Shanghai (Toripalimab, Induction chemo and concurrent chemoradiation)

Recruiting
  • Nasopharyngeal Cancer
  • Toripalimab
  • Induction chemotherapy and concurrent chemoradiation
  • Shanghai, Shanghai, China
    Fudan Universtiy Shanghai Cancer Centre
Nov 25, 2022

Verification of Harmonization of Plasma Epstein-Barr Virus DNA

Recruiting
  • Nasopharyngeal Carcinoma
  • Plasma EBV DNA qPCR test
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jul 3, 2022

Epstein-Barr Virus Infection moniToring in renAl Transplant

Recruiting
  • EBV Infection
  • +3 more
  • EBV DNA in whole blood and plasma
  • Aarhus, Central Region Denmark, Denmark
  • +2 more
Dec 12, 2022

Combining PET/CT and EBV DNA to Evaluate Hazard of Progression

Completed
  • Nasopharyngeal Carcinoma
  • PET/CT and EBV DNA
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Dec 17, 2020

NK-T-Cell Lymphoma, Extranodal Trial in Shanghai (4 cycles of ESA regimen with sandwiched radiotherapy, 2 cycles of ESA regimen

Not yet recruiting
  • NK-T-Cell Lymphoma, Extranodal
  • 4 cycles of ESA regimen with sandwiched radiotherapy
  • +2 more
  • Shanghai, Shanghai, China
    Ruijin Hospital
Sep 29, 2023

Saliva EBV-DNA Detection in EBV Infection Related Diseases

Recruiting
  • EBV Infection
  • Saliva Testing
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Mar 30, 2022

Nasopharyngeal Carcinoma Trial in Shanghai (Camrelizumab, Nimotuzumab, neoadjuvant chemo and CCRT)

Recruiting
  • Nasopharyngeal Carcinoma
  • Shanghai, Shanghai, China
    Fudan Universtiy Shanghai Cancer Centre
Mar 6, 2023

Nasopharyngeal Carcinoma Trial in Shanghai (Radiotherapy, Cisplatin)

Recruiting
  • Nasopharyngeal Carcinoma
  • Shanghai, Shanghai, China
    Fudan Universtiy Shanghai Cancer Centre
Jan 7, 2023

Nasopharyngeal Carcinoma Trial in Zhongshan, Wuzhou (Blood and saliva, P85-Ab, EBNA1-IgA, VCA-IgA and EBV DNA, Fiberoptic

Recruiting
  • Nasopharyngeal Carcinoma
  • Blood and saliva
  • +2 more
  • Zhongshan, Guangdong, China
  • +1 more
Jul 20, 2022

Nasopharyngeal Cancer Trial in Hong Kong (Adjuvant chemo (gemcitabine and cisplatin))

Completed
  • Nasopharyngeal Cancer
  • Adjuvant chemotherapy (gemcitabine and cisplatin)
  • Hong Kong, Hong Kong
  • +5 more
Feb 15, 2022

Immunotherapy With Pembrolizumab for Nasopharyngeal Carcinoma Patients Trial in Taiwan (Pembrolizumab)

Terminated
  • Immunotherapy With Pembrolizumab for Nasopharyngeal Carcinoma Patients
  • Changhua, Taiwan
  • +7 more
Apr 5, 2022

Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for

Recruiting
  • Nasopharyngeal Carcinoma
  • EBV antibodies test
  • EBV DNA test
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Jul 6, 2022

Endometrial Cancer Using Plasma Cell-free DNA Fragmentomics

Recruiting
  • Endometrial Cancer
  • low-depth whole-genome sequencing technology
  • Guangzhou, Guangdong, China
    The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Oct 9, 2023

Plasma DNA of Renal Origin in Kidney Transplant Patients

Not yet recruiting
  • Acute Kidney Injury
  • Renal Transplantation
  • determination of circulating biomarkers of renal origin circulating biomarkers of renal origin
  • Paris, France
    Nephrology-transplantation department Pitié-Salpétriêre hospital
Aug 30, 2023

Dynamic Changes of Plasma and Urine Metabolites of

Recruiting
  • Nasopharyngeal Carcinoma
  • EBV Infection
  • Proteomics technology and liquid biopsy
  • Guangzhou, Guangdong, China
    Southern medical university
Jan 4, 2023

Weekly Plasma EBV DNA for Non-metastatic Nasopharyngeal

Unknown status
  • Nasopharyngeal Carcinoma
    • Hong Kong, Hong Kong
      Department of Clinical Oncology, Queen Mary Hospital
    Sep 29, 2019

    Extranodal Natural Killer/T-cell Lymphoma Trial in Nanjing (circulate free methylated EBV DNA)

    Not yet recruiting
    • Extranodal Natural Killer/T-cell Lymphoma
    • circulate free methylated EBV DNA
    • Nanjing, China
      The First Affiliated Hospital of Nanjing Medical University
    Apr 19, 2022

    Cervical Cancer, Cervix Cancer, Cervix Tumor Trial in Sao Paulo (cisplatin, gemcitabine, Follow-up)

    Not yet recruiting
    • Cervical Cancer
    • +2 more
    • cisplatin, gemcitabine
    • Follow-up
    • Sao Paulo, Brazil
      Hospital do Coração - Research Institute
    Mar 1, 2023

    Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics

    Recruiting
    • Ovarian Cancer
      • Guangzhou, Guangdong, China
        The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
      Jan 12, 2023

      Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics

      Active, not recruiting
      • Ovarian Cancer
        • Guangzhou, Guangdong, China
          The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
        Jan 12, 2023

        Clinical Study of Pan-cancer DNA Methylation Test in Plasma

        Recruiting
        • Cancer
        • DNA methylation test
        • Zhengzhou, Henan, China
          The first affiliated hospital of Zhengzhou University
        Jan 5, 2023

        Nasopharyngeal Carcinoma, T2-3N0 or T1-2N1, EBV-DNA=4000 Copy/ml Trial in Guangzhou (Toripalimab, IMRT)

        Recruiting
        • Nasopharyngeal Carcinoma
        • +2 more
        • Guangzhou, Guangdong, China
          Yanqun Xiang
        Feb 7, 2022

        Nasopharyngeal Carcinoma Trial in Singapore (CCRT with Maintenance Tislelizumab and Metronomic Capecitabine)

        Not yet recruiting
        • Nasopharyngeal Carcinoma
        • CCRT with Maintenance Tislelizumab and Metronomic Capecitabine
        • Singapore, Singapore
        • +1 more
        Oct 16, 2023

        Azole Resistance Inducing Mutations on DNA Extracted Directly

        Recruiting
        • Invasive Aspergillosis
        • Aspergillus PCR
        • Rotterdam, Zuid Holland, Netherlands
          Erasmus Medical Center (EMC)
        Oct 5, 2023

        Nasopharyngeal Carcinoma Trial in Guangzhou (Intensity-modulated radiation therapy, Paclitaxel liposome, Cisplatin)

        Active, not recruiting
        • Nasopharyngeal Carcinoma
        • Intensity-modulated radiation therapy
        • +3 more
        • Guangzhou, Guangdong, China
          Hai Qiang Mai
        Aug 23, 2021